ATE212229T1 - Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden - Google Patents

Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden

Info

Publication number
ATE212229T1
ATE212229T1 AT96940570T AT96940570T ATE212229T1 AT E212229 T1 ATE212229 T1 AT E212229T1 AT 96940570 T AT96940570 T AT 96940570T AT 96940570 T AT96940570 T AT 96940570T AT E212229 T1 ATE212229 T1 AT E212229T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
composition containing
antimicrobial agents
gastrointestinal diseases
Prior art date
Application number
AT96940570T
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE212229T1 publication Critical patent/ATE212229T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96940570T 1995-12-07 1996-11-22 Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden ATE212229T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/569,033 US6051604A (en) 1995-12-07 1995-12-07 Methods and compositions for the prevention and treatment of gastrointestinal disorders
PCT/US1996/018654 WO1997020567A1 (en) 1995-12-07 1996-11-22 Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ATE212229T1 true ATE212229T1 (de) 2002-02-15

Family

ID=24273820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940570T ATE212229T1 (de) 1995-12-07 1996-11-22 Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden

Country Status (18)

Country Link
US (1) US6051604A (de)
EP (1) EP0865286B1 (de)
AT (1) ATE212229T1 (de)
BR (1) BR9611912A (de)
CA (1) CA2239420C (de)
CO (1) CO4790098A1 (de)
DE (1) DE69618813T2 (de)
DK (1) DK0865286T3 (de)
ES (1) ES2166912T3 (de)
IL (1) IL124730A (de)
MX (1) MX9804578A (de)
MY (1) MY127662A (de)
NO (1) NO982634L (de)
PE (1) PE37498A1 (de)
PT (1) PT865286E (de)
TR (1) TR199801022T2 (de)
TW (1) TW586927B (de)
WO (1) WO1997020567A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429211B1 (en) * 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
WO2021252371A1 (en) 2020-06-08 2021-12-16 Elevaid Therapeutics, Inc. Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (de) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
EP0222834A4 (de) * 1985-04-18 1989-10-04 Borody Thomas J Behandlung von nichtulcerativer dyspepsia mit wismutsalzen.
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3686836T2 (de) * 1985-06-13 1993-03-04 Marshall Barry James Zusammensetzungen zur behandlung von magen-darmstoerungen.
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
EP0375068A1 (de) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Mischungen von Bismuth-Verbindungen und Tetracyclinen
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
DE69117955T2 (de) * 1990-07-20 1996-09-19 Tillotts Pharma Ag, Ziefen Produkte und verfahren zur behandlung des verdauungskanals
EP0624373B1 (de) * 1993-05-11 1999-09-08 Spirig Ag Pharmazeutische Präparate Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
US6051604A (en) 2000-04-18
TR199801022T2 (xx) 1998-10-21
PE37498A1 (es) 1998-08-27
IL124730A0 (en) 1999-01-26
ES2166912T3 (es) 2002-05-01
TW586927B (en) 2004-05-11
CA2239420A1 (en) 1997-06-12
MX9804578A (es) 1998-10-31
NO982634D0 (no) 1998-06-08
EP0865286B1 (de) 2002-01-23
EP0865286A1 (de) 1998-09-23
PT865286E (pt) 2002-06-28
NO982634L (no) 1998-08-04
DE69618813T2 (de) 2002-10-02
DK0865286T3 (da) 2002-03-25
WO1997020567A1 (en) 1997-06-12
CA2239420C (en) 2003-03-18
IL124730A (en) 2003-07-31
DE69618813D1 (de) 2002-03-14
BR9611912A (pt) 1999-04-06
CO4790098A1 (es) 1999-05-31
MY127662A (en) 2006-12-29

Similar Documents

Publication Publication Date Title
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
ATE231726T1 (de) Wismuth und eine oder mehrere antimikrobielle mittel enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
ATE213637T1 (de) Bismut enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee